EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dual Inhibition of GSK3 and JAK by BIO Suppresses Osteoblast Differentiation and Mineralization of Human Mesenchymal Cells

Nihal Almuraikhi iD, Latifa Alkhamees, Sumaiya Tareen, Manikandan Muthurangan iD

Current Issues in Molecular Biology · 16.03.2026 · 48 (3) · 316

DOI: 10.3390/cimb48030316 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 16.03.2026. Verfasst von Nihal Almuraikhi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Stem Cell Unit, Department of Anatomy, College of Medicine, King Saud University, Riyadh 11461, Saudi Arabia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ongoing Researchers Funding Program, King Saud University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glycogen synthase kinase-3 (GSK3) inhibition is a commonly used approach to promote osteogenic differentiation through activation of Wnt signaling. However, 6-bromoindirubin-3′-oxime (BIO), which is commonly used for GSK3 inhibition, also targets JAK/STAT, raising the possibility of dual pathway interference during osteoblast differentiation, as both GSK3 and JAK/STAT pathways are critical regulators of osteoblastogenesis. In this study, we investigated the effect of BIO on the osteoblast differentiation of hMSCs-TERT4. While BIO had no significant effect on cell viability or apoptosis, it markedly inhibited osteoblast differentiation, as evidenced by reduced ALP activity, decreased matrix mineralization, and downregulation of osteoblast-associated markers. Microarray analysis followed by qRT-PCR validation revealed downregulation of Wnt and TGF-β pathway genes. These findings show that BIO suppresses osteoblast commitment and osteogenic differentiation, accompanied by altered Wnt- and TGF-β-related gene expression. This study provides mechanistic insight into the off-target consequences of widely used small molecules and highlights the importance of dissecting pathway-specific roles in stem cell differentiation. Understanding the interplay between GSK3 and JAK signaling is essential for optimizing pharmacological strategies in skeletal regenerative medicine. This study highlights the importance of pathway selectivity when using small molecules in stem cell-based therapies for bone regeneration.

Schlagwörter

Stichwörter der Autor:innen

GSK3 signalingJAK/STAT signalinghuman bone marrow MSCsosteoblast differentiation

Autor:innen und Institutionen

  • Stem Cell Unit, Department of Anatomy, College of Medicine, King Saud University, Riyadh 11461, Saudi Arabia.

ORCID-Profile: Nihal Almuraikhi, Manikandan Muthurangan

Förderung

  • Ongoing Researchers Funding Program
  • King Saud University

Zitieren

APA

Almuraikhi, N., Alkhamees, L., Tareen, S., & Muthurangan, M. (2026). Dual Inhibition of GSK3 and JAK by BIO Suppresses Osteoblast Differentiation and Mineralization of Human Mesenchymal Cells. Current Issues in Molecular Biology, 48(3), 316. https://doi.org/10.3390/cimb48030316

Vancouver

Almuraikhi N, Alkhamees L, Tareen S, Muthurangan M. Dual Inhibition of GSK3 and JAK by BIO Suppresses Osteoblast Differentiation and Mineralization of Human Mesenchymal Cells. Current Issues in Molecular Biology. 2026;48(3):316. doi:10.3390/cimb48030316

BibTeX
@article{Almuraikhi2026,
  author = {Almuraikhi, Nihal and Alkhamees, Latifa and Tareen, Sumaiya and Muthurangan, Manikandan},
  title = {Dual Inhibition of GSK3 and JAK by BIO Suppresses Osteoblast Differentiation and Mineralization of Human Mesenchymal Cells},
  journal = {Current Issues in Molecular Biology},
  year = {2026},
  volume = {48},
  number = {3},
  pages = {316},
  doi = {10.3390/cimb48030316}
}
Kostenlos starten →